APAD - AnTi New Bio-Tech/China Grand Pharmaceutical Healthcare
Latest Information Update: 16 Mar 2022
At a glance
- Originator AnTi New Bio-technology
- Developer AnTi New Bio-technology; China Grand Pharmaceutical and Healthcare
- Class Antibacterials
- Mechanism of Action Bacterial growth inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Sepsis